MAPT and Parkinson disease: Among these, chlorpromazine14 and the imidazoline derivative TCH-16515 were shown in vitro to boost the activity of the 20S proteasome,facilitating the degradation of α-synuclein and tau proteins,which are associated with Parkinson’s and Alzheimer’sdiseases, respectively.